Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
Jon M. Steichen, Ying‐Cing Lin, Colin Havenar‐Daughton, et al.
Science (2019) Vol. 366, Iss. 6470
Open Access | Times Cited: 213

Showing 1-25 of 213 citing articles:

Role of nanoscale antigen organization on B-cell activation probed using DNA origami
Rémi Veneziano, Tyson J. Moyer, Matthew B. Stone, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 716-723
Open Access | Times Cited: 358
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks, Nancie M. Archin, Paula M. Cannon, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2085-2098
Open Access | Times Cited: 251
CD8+ T cells in HIV control, cure and prevention
David R. Collins, Gaurav D. Gaiha, Bruce D. Walker
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 471-482
Open Access | Times Cited: 241
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes, Kevin Wiehe, Persephone Borrow, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 142-158
Open Access | Times Cited: 220
Carbohydrate-Based Macromolecular Biomaterials
Lu Su, Yingle Feng, Kongchang Wei, et al.
Chemical Reviews (2021) Vol. 121, Iss. 18, pp. 10950-11029
Open Access | Times Cited: 213
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
Yu Kato, Robert Abbott, Brian L. Freeman, et al.
Immunity (2020) Vol. 53, Iss. 3, pp. 548-563.e8
Open Access | Times Cited: 195
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
Emanuele Andreano, Ida Paciello, Giulia Piccini, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 530-535
Open Access | Times Cited: 158
Vaccination induces HIV broadly neutralizing antibody precursors in humans
David J. Leggat, Kristen W. Cohen, Jordan R. Willis, et al.
Science (2022) Vol. 378, Iss. 6623
Open Access | Times Cited: 157
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2234-2245
Open Access | Times Cited: 126
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 118
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses
Jeroen M. J. Tas, Jahyun Koo, Ying‐Cing Lin, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1856-1871.e6
Open Access | Times Cited: 103
Low protease activity in B cell follicles promotes retention of intact antigens after immunization
Aereas Aung, Ang Cui, Laura Maiorino, et al.
Science (2023) Vol. 379, Iss. 6630
Open Access | Times Cited: 63
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies
Zhenfei Xie, Ying‐Cing Lin, Jon M. Steichen, et al.
Science (2024) Vol. 384, Iss. 6697
Closed Access | Times Cited: 17
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Torben Schiffner, Ivy Phung, Rashmi Ray, et al.
Nature Immunology (2024) Vol. 25, Iss. 6, pp. 1073-1082
Open Access | Times Cited: 17
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction
Kevin Wiehe, Kevin O. Saunders, Victoria Stalls, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 5, pp. 693-709.e7
Closed Access | Times Cited: 16
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
Maureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1105-1117
Open Access | Times Cited: 4
Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions
Tiza L Nguni, Caroline Chasara, Zaza M. Ndhlovu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 126
Factors in B cell competition and immunodominance
Robert Abbott, Shane Crotty
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 120-131
Open Access | Times Cited: 80
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies
Wilton B. Williams, Robert Meyerhoff, Robert J. Edwards, et al.
Cell (2021) Vol. 184, Iss. 11, pp. 2955-2972.e25
Open Access | Times Cited: 79
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever
J. Maximilian Fels, Daniel P. Maurer, Andrew S. Herbert, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3486-3501.e21
Open Access | Times Cited: 65
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
Byungji Kim, Ryan R. Hosn, Tanaka Remba, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 241-253
Open Access | Times Cited: 63
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
Aleksandar Antanasijevic, Leigh M. Sewall, Christopher A. Cottrell, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 57
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Wanting He, Rami Musharrafieh, Ge Song, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 960-970
Open Access | Times Cited: 56
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
Zekun Mu, Kevin Wiehe, Kevin O. Saunders, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110514-110514
Open Access | Times Cited: 50
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
Jordan R. Willis, Zachary T. Berndsen, Mark Krystal, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 2149-2167.e9
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top